Patient Support Services Contact Us
Building on our success with UDENYCA® (pegfilgrastim-cbqv), we are now expanding our mission to immuno-oncology with Junshi Biosciences’ novel
Toripalimab is an investigational new drug currently being evaluated by the FDA for commercial distribution in the United States.